The Research Institute of the McGill University
Welcome,         Profile    Billing    Logout  
 5 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Auer, Rebecca
REaCT-NSQIP, NCT03663504: Comparing No Mechanical Bowel Preparation With Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery

Recruiting
4
432
Canada
No Preparation, Neomycin and Flagyl, Metronidazole
Ottawa Hospital Research Institute
Elective Colon Surgery
09/25
12/26
COV-IMMUNO, NCT04442048: Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure

Active, not recruiting
3
195
Canada
IMM-101, Observation
Canadian Cancer Trials Group, Immodulon Therapeutics Ltd, BioCan Rx, Canadian Cancer Society (CCS), ATGen Canada Inc, Canadian Centre for Applied Research in Cancer Control (ARCC), Ontario Institute for Cancer Research
Cancer, Covid-19
05/24
12/24
POISE, NCT04871412: The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III

Recruiting
3
20
Canada
Vitamin D3 Drops, Vitamin D, Coriolus Versicolor, Trident SAP 66:33 Lemon, Fish Oil, Probiotic Pro12, Probiotics, Provitalix Pure Whey Protein, Protein Powder, Theracurmin 2X, Curcumin, Green Tea Extract, EGCG, Nutrition Recommendations, Physical Activity Recommendations, Psychological Recommendations
Ottawa Hospital Research Institute, The Canadian College of Naturopathic Medicine, Lotte & John Hecht Memorial Foundation, The Centre for Health Innovation, University of Ottawa
Lung Cancer, Gastric Cancer, Esophageal Cancer
12/29
12/31
AZUR-2, NCT05855200: Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Recruiting
3
711
Europe, Canada, Japan, US, RoW
Dostarlimab, CAPEOX, FOLFOX
GlaxoSmithKline
Colonic Neoplasms, Neoplasms, Colon
12/28
12/30
RAINBOW, NCT04061512: Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

Recruiting
2/3
148
Europe
Dexamethasone, cyclophosphamide, rituximab, Rituximab, ibrutinib
University College, London, Janssen-Cilag Ltd.
Waldenstrom Macroglobulinemia
03/30
03/30
PembroWM, NCT03630042 / 2018-001767-23: Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia

Completed
2
17
Europe
Pembrolizumab, Rituximab
University College, London, Merck Sharp & Dohme LLC
Waldenstrom Macroglobulinemia
09/21
02/24
PERIOP-06, NCT05677113: A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver

Recruiting
2
115
Canada
QBECO, Placebo
Sunnybrook Health Sciences Centre
Colorectal Cancer, Liver Metastases
02/25
02/30
ZEBRA, NCT05635162: Zanubrutinib Plus Rituximab for Patients with Indolent Mantle Cell Lymphoma

Recruiting
2
50
Europe
Zanubrutinib, Rituximab
University College, London, BeiGene
Mantle Cell Lymphoma
10/28
10/28
MOHCCN-O, NCT05403177: Marathon of Hope Cancer Centres Network Study for Ontario

Recruiting
N/A
500
Canada
University Health Network, Toronto, Princess Margaret Hospital, Canada, Ontario Institute for Cancer Research, Terry Fox Research Institute, Queen's University, Kingston, Ontario, Ottawa Hospital Research Institute, Queen's University
Breast Cancer, Colorectal Cancer, Pancreas Cancer, Kidney Cancer, Prostate Cancer, Ovary Cancer, Head and Neck Cancer, Leukemia, Lymphoma, Lung Cancer, Melanoma, Solid Tumor
10/26
10/26

Download Options